Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-EGFR-HCD3514
HCD3514

Chemical Structure : HCD3514

CAS No.: 2433837-84-2

HCD3514 (HCD-3514)

Catalog No.: PC-49519Not For Human Use, Lab Use Only.

HCD3514 is a novel potent, selective, fourth-generation EGFR inhibitor targeting C797S triple mutation, strongly inhibits EGFRL858R/T790M/C797S and EGFR19del/T790M/C797S mutations with IC50 of 1.0 and 2.0 nM, respectively.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    HCD3514 is a novel potent, selective, fourth-generation EGFR inhibitor targeting C797S triple mutation, strongly inhibits EGFRL858R/T790M/C797S and EGFR19del/T790M/C797S mutations with IC50 of 1.0 and 2.0 nM, respectively.
    HCD3514 displays 78-fold selectivity over EGFR WT (IC50=156 nM), possesses more potent kinase inhibitory activity against EGFR triple mutations than brigatinib.
    HCD3514 potently inhibited the proliferation of BaF3-EGFRL858R/T790M/C797S and BaF3-EGFR19del/T790M/C797S cells with IC50 of 0.35 μM and 0.25 μM, respectively, with little effect on BaF3 parental cells (IC50=1.31 uM).
    HCD3514 also displayed an excellent antiproliferative potency in PC-9-OR cells, with IC50 of 0.48 μM, which was similar to that of brigatinib (IC50=0.40 μM) and more potent than AZD9291 (IC50=6.30 μM).
    HCD3514 potently and dose-dependently suppressed the EGFR phosphorylation in both triple mutant BaF3 cells and PC-9-OR cells.
    HCD3514 triggered significant apoptosis with apoptosis rates of 72.39% and 98.27% at 1 uM and 3 uM in BaF3-EGFRL858R/T790M/C797S cells, respectively.
    HCD3514 (50 and 75 mg/kg, oral) suppressed tumor growth in EGFRC797S triple mutant BaF3 xenograft model.
    HCD3514 potently inhibited EGFRL858R/T790M and EGFR19del/T790M mutations with IC50 values of 4.9 and 8.9 nM in biochemical, respectively.
    HCD3514 showed antiproliferative activities in BaF3-EGFRL858R/T790M and BaF3-EGFR19del/T790M cells with IC50 of 0.66 μM and 0.52 μM, respectively.
    HCD3514 exhibited in vitro anti-tumor activity of HCD3514 in NCI-H1975 cells harboring EGFRL858R/T790M (IC50=0.49 uM).

    Physicochemical Properties

    M.Wt 652.26
    Formula C33H42ClN7O3S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    5-chloro-4-(1-(ethylsulfonyl)-1H-indol-3-yl)-N-(3-isopropoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-2-amine

    References

    1. Lai M, et al. J Cancer. 2023 Jan 1;14(1):152-162.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: